Open Label Pilot Efficacy and Safety Study of GLYX-13 in Subjects with Neuropathic Pain

Trial Profile

Open Label Pilot Efficacy and Safety Study of GLYX-13 in Subjects with Neuropathic Pain

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Mar 2016

At a glance

  • Drugs Rapastinel (Primary)
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Sponsors Naurex
  • Most Recent Events

    • 27 Feb 2016 Status changed from recruiting to completed, as reported by ISRCTN: Current Controlled Trials.
    • 12 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top